Neurocrine Biosciences: Buy Rated As Q3 2025 Earnings Catalyst Approaches
Neurocrine(US:NBIX) Seeking Alphaยท2025-10-18 08:47Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) stock has had a stellar six-month performance with double-digit gains, recovering from 52-week lows recorded in April 2025. However, the past month has been slowish, with marginal losses of below one percent. That said, theGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital ...